Literature DB >> 3972984

Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children.

M J Blaser, R E Black, D J Duncan, J Amer.   

Abstract

In Bangladesh and other developing countries, isolation of Campylobacter jejuni is common in healthy children, and the illness/infection ratio falls with age. To determine whether specific serum antibodies correlate with this phenomenon, using an enzyme-linked immunosorbent assay, we studied sera from 93 healthy Bangladeshi children and 121 healthy U.S. children under 15 years of age. For each age group (less than 1, 2 to 4, and 5 to 14 years) studied, specific serum antibody levels were significantly higher in the Bangladeshi children. Among Bangladeshi children, for each of the three immunoglobulin subclasses, the change in antibody levels with age was different. Specific immunoglobulin A antibody levels rose linearly with age, immunoglobulin G levels peaked in the 2- to 4-year age group and then fell, and immunoglobulin M levels peaked in the 2- to 4-year age group and then plateaued. Elevated serum antibody levels to C. jejuni in Bangladeshi children may be protective in themselves or may reflect other protective phenomena.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972984      PMCID: PMC271606          DOI: 10.1128/jcm.21.2.164-167.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  COPROANTIBODY AND SERUM ANTIBODY IN CHOLERA PATIENTS.

Authors:  R FRETER; S P DE; A MONDAL; D L SHRIVASTAVA; F W SUNDERMAN
Journal:  J Infect Dis       Date:  1965-02       Impact factor: 5.226

2.  Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults.

Authors:  D S Rowe; I A McGregor; S J Smith; P Hall; K Williams
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

3.  Serum immunoglobulin levels in healthy children and adults.

Authors:  J W Stoop; B J Zegers; P C Sander; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

4.  Immunoglobulin concentrations in sera of normal children: quantitation against an international reference preparation.

Authors:  J Cejka; D W Mood; C S Kim
Journal:  Clin Chem       Date:  1974-06       Impact factor: 8.327

5.  A proposed mechanism for natural immunity to enterobacterial pathogens.

Authors:  L Chedid; M Parant; F Parant; F Boyer
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

Review 6.  Epidemiology of Campylobacter jejuni infections.

Authors:  M J Blaser; D N Taylor; R A Feldman
Journal:  Epidemiol Rev       Date:  1983       Impact factor: 6.222

7.  Age-specific prevalence of antibody to rotavirus, Escherichia coli heat-labile enterotoxin, Norwalk virus, and hepatitis A virus in a rural community in Thailand.

Authors:  P Echeverria; D S Burke; N R Blacklow; G Cukor; C Charoenkul; S Yanggratoke
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

8.  Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay.

Authors:  M J Blaser; D J Duncan
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Persistent Campylobacter jejuni infection in an immunocompromised patient.

Authors:  R J Johnson; C Nolan; S P Wang; W R Shelton; M J Blaser
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

10.  Campylobacter enteritis in the United States. A multicenter study.

Authors:  M J Blaser; J G Wells; R A Feldman; R A Pollard; J R Allen
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

View more
  31 in total

1.  Immunoglobulin KM genes in Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Christian A Vedeler
Journal:  Neurogenetics       Date:  2003-02-11       Impact factor: 2.660

2.  Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells.

Authors:  Chia-Der Lin; Cheng-Kuo Lai; Yu-Hsin Lin; Jer-Tsong Hsieh; Yu-Ting Sing; Yun-Chieh Chang; Kai-Chuan Chen; Wen-Ching Wang; Hong-Lin Su; Chih-Ho Lai
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

Review 3.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Mucosal and systemic immunity to Campylobacter jejuni in rabbits after gastric inoculation.

Authors:  D H Burr; M B Caldwell; A L Bourgeois; H R Morgan; R Wistar; R I Walker
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  Experimental Campylobacter jejuni infection in Macaca nemestrina.

Authors:  R G Russell; M J Blaser; J I Sarmiento; J Fox
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

7.  Immune response of athymic and euthymic germfree mice to Campylobacter spp.

Authors:  J W Yrios; E Balish
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.

Authors:  S Baqar; N D Pacheco; F M Rollwagen
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 9.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

10.  Evidence of reinfection with multiple strains of Campylobacter jejuni and Campylobacter coli in Macaca nemestrina housed under hyperendemic conditions.

Authors:  R G Russell; J I Sarmiento; J Fox; P Panigrahi
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.